Membranous nephropathy in a patient with COVID-19 infection
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Nephrology"
DOI: 10.1007/s40620-021-01165-0
Abstract: A 29-year-old South Asian male presented with fever, myalgia and lower limb swelling of 3 days duration. Four weeks prior to presentation, he had been diagnosed with COVID19 infection and was treated symptomatically in the… read more here.
Keywords: pla2r antibody; creatinine; patient; serum ... See more keywords
Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy
Sign Up to like & getrecommendations! Published in 2022 at "Renal Failure"
DOI: 10.1080/0886022x.2022.2057861
Abstract: Abstract Background Primary membranous nephropathy (PMN) is associated with the highest risk for developing venous thrombosis compared with other nephrotic diseases. The aim of the study was to assess the predictive value of the pathognomonic… read more here.
Keywords: venous thrombosis; thrombosis; pla2r antibody; anti pla2r ... See more keywords
MO300PHOSPHOLIPASE A2 RECEPTOR ANTIBODY SCREENING IN NEPHROTIC SYNDROME MAY IDENTIFY A DISTINCT SUBSET OF PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY
Sign Up to like & getrecommendations! Published in 2021 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfab104.0058
Abstract: Primary membranous nephropathy (MN) is a glomerulus-specific autoimmune disorder caused by anti-phospholipase A2 receptor (anti-PLA2R) antibodies in 70-80% of cases. We sought to investigate the utility of anti-PLA2R antibody as a non-invasive screening method for… read more here.
Keywords: diagnosis; titer; anti pla2r; pla2r antibody ... See more keywords
Response Predictors to Calcineurin Inhibitors in Patients with Primary Membranous Nephropathy
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Nephrology"
DOI: 10.1159/000488728
Abstract: Background: Currently, there is an urgent need to find ways of identifying primary membranous nephropathy (PMN) patients who are likely to benefit from calcineurin inhibitors (CNI) or who are resistant to them. In this study,… read more here.
Keywords: pmn patients; calcineurin inhibitors; membranous nephropathy; pla2r antibody ... See more keywords
Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec’s Reference Center
Sign Up to like & getrecommendations! Published in 2021 at "Canadian Journal of Kidney Health and Disease"
DOI: 10.1177/20543581211052729
Abstract: Background: Quantification of the M-type phospholipase A2 receptor antibodies (anti-PLA2R) is now an essential tool for diagnosis and management of primary membranous nephropathy (MN). Since October 2018, Hôpital Maisonneuve-Rosemont (HMR) has been designated as Quebec’s… read more here.
Keywords: year; anti pla2r; quebec; test ... See more keywords
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0281726
Abstract: Background Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology practice has not changed dramatically, with most nephrologists still relying on a kidney biopsy to diagnose membranous nephropathy. In this study, we examined the… read more here.
Keywords: anti pla2r; pla2r; pla2r antibody; test ... See more keywords